We have signed a letter of intent and a non-disclosure agreement with Eckert and
Ziegler to determine if forming a business relationship is in both companies’ best interests. E&Z has an excellent reputation for providing radioactive products for other
clients. They currently supply our yttrium-90 so expanding their role could reduce the shipping cost and logistic issues.
Eckert & Ziegler has assessed our proprietary
production procedures and this week their representative observed a full production run at IsoTherapeutics, our current component supplier. It is important to analyze the production requirements and business aspects in detail. We anticipate that this
thorough analysis will take considerable time. This is necessary to create a long-term relationship.
Mike Korenko, Sc. D.
CEO • President | Vivos Inc.